Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Xcovery Holding Co. LLC
DescriptionSelective inhibitor of the P110delta isoform of PI3K
Molecular Target Phosphoinositide 3-kinase (PI3K) catalytic subunit delta polypeptide (PI3KCD) (p110delta)
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationChronic lymphocytic leukemia (CLL)
Indication DetailsTreat B cell chronic lymphocytic leukemia (B-CLL)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today